BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24334765)

  • 1. The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function.
    Qin Y; Deng Y; Ricketts CJ; Srikantan S; Wang E; Maher ER; Dahia PL
    Hum Mol Genet; 2014 May; 23(9):2428-39. PubMed ID: 24334765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
    Yao L; Schiavi F; Cascon A; Qin Y; Inglada-Pérez L; King EE; Toledo RA; Ercolino T; Rapizzi E; Ricketts CJ; Mori L; Giacchè M; Mendola A; Taschin E; Boaretto F; Loli P; Iacobone M; Rossi GP; Biondi B; Lima-Junior JV; Kater CE; Bex M; Vikkula M; Grossman AB; Gruber SB; Barontini M; Persu A; Castellano M; Toledo SP; Maher ER; Mannelli M; Opocher G; Robledo M; Dahia PL
    JAMA; 2010 Dec; 304(23):2611-9. PubMed ID: 21156949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.
    Qin Y; Yao L; King EE; Buddavarapu K; Lenci RE; Chocron ES; Lechleiter JD; Sass M; Aronin N; Schiavi F; Boaretto F; Opocher G; Toledo RA; Toledo SP; Stiles C; Aguiar RC; Dahia PL
    Nat Genet; 2010 Mar; 42(3):229-33. PubMed ID: 20154675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex.
    Deng Y; Qin Y; Srikantan S; Luo A; Cheng ZM; Flores SK; Vogel KS; Wang E; Dahia PLM
    Hum Mol Genet; 2018 May; 27(10):1794-1808. PubMed ID: 29547888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
    Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of TMEM127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking.
    Flores SK; Deng Y; Cheng Z; Zhang X; Tao S; Saliba A; Chu I; Burnichon N; Gimenez-Roqueplo AP; Wang E; Aguiar RCT; Dahia PLM
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3142-56. PubMed ID: 32575117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-regulation of defective endolysosome trafficking and enhanced autophagy through TFEB in UNC13D deficiency.
    Zhang J; He J; Johnson JL; Napolitano G; Ramadass M; Rahman F; Catz SD
    Autophagy; 2019 Oct; 15(10):1738-1756. PubMed ID: 30892133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma.
    Burnichon N; Lepoutre-Lussey C; Laffaire J; Gadessaud N; Molinié V; Hernigou A; Plouin PF; Jeunemaitre X; Favier J; Gimenez-Roqueplo AP
    Eur J Endocrinol; 2011 Jan; 164(1):141-5. PubMed ID: 20923864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
    Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Söderkvist P; Stenman A; Larsson C; Svahn F; Chen JL; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay Ö; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH;
    JAMA Oncol; 2017 Sep; 3(9):1204-1212. PubMed ID: 28384794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identical germline mutations in the TMEM127 gene in two unrelated Japanese patients with bilateral pheochromocytoma.
    Takeichi N; Midorikawa S; Watanabe A; Naing BT; Tamura H; Wakakuri-Kano T; Ishizaki A; Sugihara H; Nissato S; Saito Y; Aita Y; Ishii KA; Igarashi T; Kawakami Y; Hara H; Ikeda T; Shimizu K; Suzuki S; Shimano H; Kawamoto M; Shimada T; Watanabe T; Oikawa S; Takekoshi K
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):707-14. PubMed ID: 22541004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association.
    Hernandez KG; Ezzat S; Morel CF; Swallow C; Otremba M; Dickson BC; Asa SL; Mete O
    Virchows Arch; 2015 Jun; 466(6):727-32. PubMed ID: 25800244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minireview: the busy road to pheochromocytomas and paragangliomas has a new member, TMEM127.
    Jiang S; Dahia PL
    Endocrinology; 2011 Jun; 152(6):2133-40. PubMed ID: 21447639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.
    Armaiz-Pena G; Flores SK; Cheng ZM; Zhang X; Esquivel E; Poullard N; Vaidyanathan A; Liu Q; Michalek J; Santillan-Gomez AA; Liss M; Ahmadi S; Katselnik D; Maldonado E; Salgado SA; Jimenez C; Fishbein L; Hamidi O; Else T; Lechan R; Tischler AS; Benn DE; Dwight T; Clifton-Bligh R; Sanso G; Barontini M; Vincent D; Aronin N; Biondi B; Koops M; Bowhay-Carnes E; Gimenez-Roqueplo AP; Alvarez-Eslava A; Bruder JM; Kitano M; Burnichon N; Ding Y; Dahia PLM
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e350-e364. PubMed ID: 33051659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics.
    Walker TJ; Reyes-Alvarez E; Hyndman BD; Sugiyama MG; Oliveira LCB; Rekab AN; Crupi MJF; Cabral-Dias R; Guo Q; Dahia PLM; Richardson DS; Antonescu CN; Mulligan LM
    Elife; 2024 Apr; 12():. PubMed ID: 38687678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous TMEM127 mutations in 2 patients with bilateral pheochromocytomas.
    Eijkelenkamp K; Olderode-Berends MJW; van der Luijt RB; Robledo M; van Dooren M; Feelders RA; de Vries J; Kerstens MN; Links TP; van der Horst-Schrivers ANA
    Clin Genet; 2018 May; 93(5):1049-1056. PubMed ID: 29282712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential roles for phosphatidylinositol 3-phosphate and Rab5 in tethering and fusion of early endosomes via their interaction with EEA1.
    Lawe DC; Chawla A; Merithew E; Dumas J; Carrington W; Fogarty K; Lifshitz L; Tuft R; Lambright D; Corvera S
    J Biol Chem; 2002 Mar; 277(10):8611-7. PubMed ID: 11602609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a symmetrical requirement for Rab5-GTP in in vitro endosome-endosome fusion.
    Barbieri MA; Hoffenberg S; Roberts R; Mukhopadhyay A; Pomrehn A; Dickey BF; Stahl PD
    J Biol Chem; 1998 Oct; 273(40):25850-5. PubMed ID: 9748259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma.
    Kawakami T; Chano T; Minami K; Okabe H; Okada Y; Okamoto K
    Hum Mol Genet; 2006 Mar; 15(6):821-30. PubMed ID: 16439445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The small GTPase Rab22 interacts with EEA1 and controls endosomal membrane trafficking.
    Kauppi M; Simonsen A; Bremnes B; Vieira A; Callaghan J; Stenmark H; Olkkonen VM
    J Cell Sci; 2002 Mar; 115(Pt 5):899-911. PubMed ID: 11870209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites.
    Neumann HP; Sullivan M; Winter A; Malinoc A; Hoffmann MM; Boedeker CC; Bertz H; Walz MK; Moeller LC; Schmid KW; Eng C
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1279-82. PubMed ID: 21613359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.